Literature DB >> 2319735

[Effect of diabetes-psychosomatic group education on metabolic control and coping with disease by insulin-dependent diabetic patients].

C Albus1, G Ollenschläger, W Thomas, H Fischer, H M Schäfer, R Peters.   

Abstract

Even though cognitive education programs are essential for the treatment of diabetics, long term efficacy often seems to be poor. Problems of coping with illness could be the reason for a lack of transfer of knowledge into daily practice. Small discussion groups with the aim of modifying attitudes towards illness might be a good possibility to face this problem. 54 IDDM, HbA1 10.7 +/- 2.3% (median +/- SD) absolved our 5-day education program for outpatients, in which daily group sessions (90 min), supervised by a group-therapist, were integrated. Follow-up sessions took place after 1, 4 and 8 months. The efficacy was measured by HbA1 and different questionnaires on diabetologic knowledge, life satisfaction (FLZ) and complaints (BL). 4 months after the education program HbA1 had decreased to 9.0 (median +/- SD) and remained stable within small range during the rest of the study-period. Diabetologic knowledge increased from 70% (median +/- SD) to 87% (median +/- SD) 1 month after the education and remained stable during the rest of the study-period. Complaints decreased within one month from a level above average somatic illness to the normal level for healthy subjects. However, in regard to their life satisfaction our patients were significantly less satisfied concerning their health, whereas family life and friendship were declared to be more satisfying (after 8 months). We believe that more intensive communication in the family (encouraged by the group-therapy) and parallel more critical attitudes towards illness lead to this results. As basic elements for long term modification of illness behaviour these emotional aspects seem to be essential.

Entities:  

Mesh:

Year:  1990        PMID: 2319735     DOI: 10.1007/bf01646847

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  9 in total

1.  [Group therapy in insulin-dependent diabetics].

Authors:  T Haenel; O Staffelbach; W Berger
Journal:  Schweiz Rundsch Med Prax       Date:  1986-05-13

2.  Does patient education in chronic disease have therapeutic value?

Authors:  S A Mazzuca
Journal:  J Chronic Dis       Date:  1982

3.  [Behavioral medicine aspects of juvenile diabetes].

Authors:  R Roth
Journal:  Wien Med Wochenschr       Date:  1986-10-31

4.  Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months.

Authors:  I Mühlhauser; V Jörgens; M Berger; W Graninger; W Gürtler; L Hornke; A Kunz; G Schernthaner; V Scholz; H E Voss
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

5.  Randomized, controlled trial of diabetic patient education: improved knowledge without improved metabolic status.

Authors:  Z T Bloomgarden; W Karmally; M J Metzger; M Brothers; C Nechemias; J Bookman; D Faierman; F Ginsberg-Fellner; E Rayfield; W V Brown
Journal:  Diabetes Care       Date:  1987 May-Jun       Impact factor: 19.112

6.  Social learning intervention to promote metabolic control in type I diabetes mellitus: pilot experiment results.

Authors:  R M Kaplan; M W Chadwick; L E Schimmel
Journal:  Diabetes Care       Date:  1985 Mar-Apr       Impact factor: 19.112

7.  The practice of group psychotherapy with adult insulin-dependent diabetics.

Authors:  M O Aveline; D K McCulloch; R B Tattersall
Journal:  Diabet Med       Date:  1985-07       Impact factor: 4.359

8.  Management and efficacy of intensified insulin therapy--starting in outpatients.

Authors:  G Ollenschläger; W Hummerich; M Steffen; M Reincke; B Allolio; W Winkelmann
Journal:  Klin Wochenschr       Date:  1989-01-20

Review 9.  Group therapy in the treatment of diabetes.

Authors:  R B Tattersall; D K McCulloch; M Aveline
Journal:  Diabetes Care       Date:  1985 Mar-Apr       Impact factor: 19.112

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.